The Business Times
business-time-50

Inex, Nova Satra merge to tackle healthcare for Asian women

google-preferred-sourceAdd BT as a preferred source
Claudia Chong

Claudia Chong

Published Tue, Aug 20, 2019 · 09:50 PM

    Singapore

    SINGAPORE molecular diagnostics groups Inex Innovations Exchange and Nova Satra Dx have merged to form Inex Innovate, in a deal valued at US$72 million and backed by institutional investors including Genting Berhad, Enterprise Singapore and SNS Holdings. SNS Holdings is an investment company owned by Singaporean entrepreneur Sim Giok Lak and his family.

    The combined company will be focused on addressing the unmet need for faster and more accurate diagnostics testing and precision healthcare for Asian women.

    TRENDING NOW

    Out of the 18,000 fresh graduates, 9,100 have found employment and 5,400 are outside the labour force, mainly for voluntary reasons.

    1 in 5 fresh graduates from autonomous universities still seeking employment: MOM

    For H1 2026, Seatrium’s net profit jumped 158.3% year on year to S$372.9 million.

    Can Seatrium build on its robust H1 earnings? UOBKH and DBS analysts have divided views

    Grant Wee built Hideaway as a massage-and-bathhouse concept centred on solitude and recovery.

    UOB CEO’s youngest child Grant Wee turns burnout into a wellness business

    UOB group chief financial officer Leong Yung Chee (left) and AllianzGI CEO Tobias Pross at the signing of the strategic distribution partnership.

    UOB to sell asset management arm to Allianz Global Investors for S$555 million, sharpen wealth advisory focus

    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More